Atlas Trials

Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)

Clinical trial NCT01069861 · TERMINATED

Trial details

NCT number
NCT01069861
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
PPHNPersistent Pulmonary Hypertension of the NewbornHypoxic Respiratory Failure
Start date
2010-12-01
Primary completion
2011-11-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.